Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
26.68
+0.34 (1.29%)
At close: Jun 26, 2026, 4:00 PM EDT
26.75
+0.07 (0.26%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Mineralys Therapeutics Employees
Mineralys Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 25 or 49.02% compared to the previous year.
Employees
76
Change (1Y)
25
Growth (1Y)
49.02%
Revenue / Employee
n/a
Profits / Employee
-$1,997,092
Market Cap
2.35B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 25 | 49.02% |
| Dec 31, 2024 | 51 | 23 | 82.14% |
| Dec 31, 2023 | 28 | 16 | 133.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Harmony Biosciences Holdings | 293 |
| Precigen | 160 |
| Kodiak Sciences | 130 |
| Aurinia Pharmaceuticals | 128 |
MLYS News
- 13 days ago - Mineralys Therapeutics presents late-breaking data on lorundrostat - TheFly
- 13 days ago - Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) - GlobeNewsWire
- 18 days ago - Mineralys Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 19 days ago - Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire
- 20 days ago - Mineralys Therapeutics to Present Late-Breaking Data on Lorundrostat at The Endocrine Society Annual Meeting (ENDO 2026) - GlobeNewsWire
- 24 days ago - Mineralys Therapeutics falls -17.1% - TheFly
- 24 days ago - Mineralys Therapeutics falls -12.7% - TheFly
- 24 days ago - Mineralys prices offering of 5.66M shares of common stock at $26.50 - TheFly